{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:39:22Z","timestamp":1765039162035},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,3,12]],"date-time":"2011-03-12T00:00:00Z","timestamp":1299888000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s11096-011-9493-2","type":"journal-article","created":{"date-parts":[[2011,3,11]],"date-time":"2011-03-11T03:06:46Z","timestamp":1299812806000},"page":"273-280","source":"Crossref","is-referenced-by-count":42,"title":["Effects of a pharmacotherapy follow-up in community pharmacies on type 2 diabetes patients in Brazil"],"prefix":"10.1007","volume":"33","author":[{"given":"Cassyano Janu\u00e1rio","family":"Correr","sequence":"first","affiliation":[]},{"given":"Ana Carolina","family":"Melchiors","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Fernandez-Llimos","sequence":"additional","affiliation":[]},{"given":"Roberto","family":"Pontarolo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2011,3,12]]},"reference":[{"issue":"6865","key":"9493_CR1","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/414782a","volume":"414","author":"P Zimmet","year":"2001","unstructured":"Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414(6865):782\u20137.","journal-title":"Nature"},{"key":"9493_CR2","unstructured":"Sociedade Brasileira de Diabetes. Tratamento e acompanhamento do diabetes mellitus. Diretrizes da Sociedade Brasileira de Diabetes. [Treatment and follow-up of diabetes mellitus. Guidelines of Brazilian Diabetes Society]. Rio de Janeiro: Diagraphic; 2007. 164 p. 85-89718-15-8."},{"key":"9493_CR3","doi-asserted-by":"crossref","unstructured":"Assuncao MC, Santos IS, Valle NC. Controle glic\u00eamico em pacientes diab\u00e9ticos atendidos em centros de aten\u00e7\u00e3o prim\u00e1ria \u00e0 sa\u00fade. [Blood glucose control in diabetes patients seen in primary health care centers]. Rev Saude Publica. 2005;39(2):183\u201390.","DOI":"10.1590\/S0034-89102005000200007"},{"issue":"2","key":"9493_CR4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1900\/RDS.2006.3.82","volume":"3","author":"MB Gomes","year":"2006","unstructured":"Gomes MB, Gianella D, Faria M, Tambascia M, Fonseca RM, Rea R, et al. Prevalence of Type 2 diabetic patients within the targets of care guidelines in daily clinical practice: a multi-center study in Brazil. Rev Diabet Stud. 2006;3(2):82\u20137.","journal-title":"Rev Diabet Stud"},{"key":"9493_CR5","unstructured":"Ivama AM, Noblat L, DeCastro MS, DeOliveira NVBV, Jaramillo NM, Rech N. Consenso Brasileiro de aten\u00e7\u00e3o farmac\u00eautica. [Brazilian Consensus about Pharmaceutical Care]. Bras\u00edlia: PAHO\/WHO; 2002. 24 p. 85-87 943-12-X."},{"key":"9493_CR6","unstructured":"Fernandez-Llimos F, Faus MJ. From \u201cdrug-related problems\u201d to \u201cnegative clinical outcomes\u201d. Am J Health Syst Pharm. 2005;62(22):2348, 50."},{"key":"9493_CR7","doi-asserted-by":"crossref","unstructured":"de Castro MS, Fuchs FD, Santos MC, Maximiliano P, Gus M, Moreira LB, et al. Pharmaceutical care program for patients with uncontrolled hypertension. Report of a double-blind clinical trial with ambulatory blood pressure monitoring. Am J Hypertens. 2006;19(5):528\u201333.","DOI":"10.1016\/j.amjhyper.2005.11.009"},{"issue":"18","key":"9493_CR8","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.2146\/ajhp060547","volume":"64","author":"WA Souza de","year":"2007","unstructured":"de Souza WA, Yugar-Toledo JC, Bergsten-Mendes G, Sabha M, Moreno H Jr. Effect of pharmaceutical care on blood pressure control and health-related quality of life in patients with resistant hypertension. Am J Health Syst Pharm. 2007;64(18):1955\u201361.","journal-title":"Am J Health Syst Pharm"},{"issue":"30","key":"9493_CR9","first-page":"30","volume":"3","author":"D Lyra Junior","year":"2004","unstructured":"Lyra Junior D, Amaral RT, Abriata JP, Pel\u00e1 IR. Satisfaction as an outcome of a pharmaceutical care program for elderly in Ribeir\u00e3o Preto\u2013S\u00e3o Paulo (Brazil). Seguimiento Farmacoterap\u00e9utico. 2004;3(30):30\u201342.","journal-title":"Seguimiento Farmacoterap\u00e9utico"},{"issue":"9","key":"9493_CR10","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1345\/aph.1K080","volume":"41","author":"MS Castro de","year":"2007","unstructured":"de Castro MS, Correr CJ. Pharmaceutical care in community pharmacies: practice and research in Brazil. Ann Pharmacother. 2007;41(9):1486\u201393.","journal-title":"Ann Pharmacother"},{"key":"9493_CR11","unstructured":"Fern\u00e1ndez-Llim\u00f3s F, Faus MJ, Gastelurrutia MA, Baena MI, Tuneu L, Martinez-Martinez F. Identificaci\u00f3n sistem\u00e1tica de resultados cl\u00ednicos negativos de la farmacoterapia. [Systematic identification of negative clinical outcomes from pharmacotherapy]. Seguimiento Farmacoterap\u00e9utico. 2004;2(3):195\u2013205."},{"key":"9493_CR12","unstructured":"Aguas Y, Fernandez-Llimos F. Curso de iniciaci\u00f3n al seguimiento farmacoterap\u00e9utico. [Initiation course on pharmacotherapy follow-up]. Badajoz: CIPF; 2009. p. 978-84-613-6255-4."},{"key":"9493_CR13","unstructured":"Sabater D, Fern\u00e1ndez-Llim\u00f3s F, Parras M, Faus MJ. Tipos de intervenciones farmac\u00e9uticas en seguimiento farmacoterap\u00e9utico. [Types of pharmacist intervention in pharmacotherapy follow-up]. Seguimiento Farmacoterap\u00e9utico. 2005;3(2)."},{"issue":"5","key":"9493_CR14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"issue":"4","key":"9493_CR15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1590\/S0066-782X2007001600001","volume":"89","author":"AC Melchiors","year":"2007","unstructured":"Melchiors AC, Correr CJ, Fernandez-Llimos F. Translation and validation into Portuguese language of the medication regimen complexity index. Arq Bras Cardiol. 2007;89(4):210\u20138.","journal-title":"Arq Bras Cardiol"},{"issue":"9","key":"9493_CR16","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1345\/aph.1D479","volume":"38","author":"J George","year":"2004","unstructured":"George J, Phun YT, Bailey MJ, Kong DC, Stewart K. Development and validation of the medication regimen complexity index. Ann Pharmacother. 2004;38(9):1369\u201376.","journal-title":"Ann Pharmacother"},{"key":"9493_CR17","unstructured":"Sociedade Brasileira de Cardiologia, Sociedade Brasileira de Hipertens\u00e3o, Sociedade Brasileira de Nefrologia. V Diretrizes Brasileiras de Hipertens\u00e3o. [V Brazilian Guidelines of Hypertension]. S\u00e3o Paulo: SBC; 2006 [cited 2009 01 Sep]; Available from: http:\/\/publicacoes.cardiol.br\/consenso\/2006\/VDiretriz-HA.pdf ."},{"key":"9493_CR18","unstructured":"Sociedade Brasileira de Endocrinologia e Metabologia, Sociedade Brasileira de Nefrologia. Diabetes Mellitus: Tratamento da Hipertens\u00e3o Arterial. [Diabetes Mellitus: Treatment of hypertension]. Rio de Janeiro: AMB-CFM; 2004 [cited 2010 20 oct]; Available from: http:\/\/www.projetodiretrizes.org.br\/4_volume\/12-tratament.pdf ."},{"key":"9493_CR19","unstructured":"Sociedade Brasileira de Hipertens\u00e3o, Sociedade Brasileira de Cardiologia, Sociedade Brasileira de Endocrinologia e Metabologia, Sociedade Brasileira de Diabetes, Associa\u00e7\u00e3o Brasileira para estudos da Obesidade. I Diretriz Brasileira de diagn\u00f3stico e tratamento da s\u00edndrome metab\u00f3lica. [I Brazilian Guideline of diagnose and treatment of metabolic syndrome]. S\u00e3o Paulo; 2005 [cited 2006 set 25]; Available from: http:\/\/publicacoes.cardiol.br\/consenso\/2005\/sindromemetabolica.pdf ."},{"issue":"10","key":"9493_CR20","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1345\/aph.1K151","volume":"41","author":"M Machado","year":"2007","unstructured":"Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management. Ann Pharmacother. 2007;41(10):1569\u201382.","journal-title":"Ann Pharmacother"},{"issue":"11","key":"9493_CR21","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/archinte.162.11.1301","volume":"162","author":"A Raji","year":"2002","unstructured":"Raji A, Gomes H, Beard JO, MacDonald P, Conlin PR. A randomized trial comparing intensive and passive education in patients with diabetes mellitus. Arch Intern Med. 2002;162(11):1301\u20134.","journal-title":"Arch Intern Med"},{"issue":"3","key":"9493_CR22","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/106002809603000305","volume":"30","author":"LA Jaber","year":"1996","unstructured":"Jaber LA, Halapy H, Fernet M, Tummalapalli S, Diwakaran H. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother. 1996;30(3):238\u201343.","journal-title":"Ann Pharmacother"},{"issue":"4","key":"9493_CR23","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1590\/S0034-89102010000400007","volume":"44","author":"ML Cherchiglia","year":"2010","unstructured":"Cherchiglia ML, Machado EL, Szuster DA, Andrade EI, Assis Acurcio F, Caiaffa WT, et al. Epidemiological profile of patients on renal replacement therapy in Brazil, 2000\u20132004. Rev Saude Publica. 2010;44(4):639\u201349.","journal-title":"Rev Saude Publica"},{"issue":"4","key":"9493_CR24","first-page":"253","volume":"11","author":"HM Choe","year":"2005","unstructured":"Choe HM, Mitrovich S, Dubay D, Hayward RA, Krein SL, Vijan S. Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. Am J Manag Care. 2005;11(4):253\u201360.","journal-title":"Am J Manag Care"},{"issue":"2","key":"9493_CR25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00592-009-0138-z","volume":"47","author":"AB Mendes","year":"2010","unstructured":"Mendes AB, Fittipaldi JA, Neves RC, Chacra AR, Moreira ED Jr. Prevalence and correlates of inadequate glycaemic control: results from a nationwide survey in 6,671 adults with diabetes in Brazil. Acta Diabetol. 2010;47(2):137\u201345.","journal-title":"Acta Diabetol"},{"issue":"7258","key":"9493_CR26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","volume":"321","author":"IM Stratton","year":"2000","unstructured":"Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Bmj. 2000;321(7258):405\u201312.","journal-title":"Bmj"},{"issue":"2","key":"9493_CR27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1331\/108658003321480713","volume":"43","author":"CW Cranor","year":"2003","unstructured":"Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash). 2003;43(2):173\u201384.","journal-title":"J Am Pharm Assoc (Wash)"},{"issue":"4","key":"9493_CR28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1331\/1544345041475625","volume":"44","author":"CL Armour","year":"2003","unstructured":"Armour CL, Taylor SJ, Hourihan F, Smith C, Krass I. Implementation and evaluation of Australian pharmacists\u2019 diabetes care services. J Am Pharm Assoc (2003). 2003;44(4):455\u201366.","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"3","key":"9493_CR29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.pec.2003.10.009","volume":"53","author":"A Sarkadi","year":"2004","unstructured":"Sarkadi A, Rosenqvist U. Experience-based group education in Type 2 diabetes: a randomised controlled trial. Patient Educ Couns. 2004;53(3):291\u20138.","journal-title":"Patient Educ Couns"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-011-9493-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-011-9493-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-011-9493-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T06:11:14Z","timestamp":1560060674000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-011-9493-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,12]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["9493"],"URL":"https:\/\/doi.org\/10.1007\/s11096-011-9493-2","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,12]]}}}